Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 12.11.2024
MEI Pharma Мультипликаторы 2011-2024 | MEIP
Мультипликаторы по годам MEI Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
1.2 | -1.5 | -0.1 | -5.4 | -5.8 | -7.4 | -3.8 | 40.7 | -2.2 | -1.4 | -5.1 | -6.8 | -0.7 | -2.4 |
P/S |
0.3 | 1.0 | 0.1 | 6.5 | 9.8 | 25.2 | 93.7 | 4.7 | - | - | - | - | - | - |
EPS |
2.7 | -4.8 | -8.8 | -0.4 | -0.5 | -0.2 | -1.0 | 0.1 | -0.6 | -1.2 | -1.4 | -1.1 | -0.6 | -0.9 |
EV (Enterprise Value) |
25.6 млн | 128 млн | 113 млн | 341 млн | 392 млн | 149 млн | 193 млн | 105 млн | 41.5 млн | 31.4 млн | 128 млн | 42 млн | 1.1 млн | 15.1 млн |
EBITDA per Share |
2.24 | -5.46 | -12.1 | -0.53 | -0.28 | -0.649 | -0.689 | 0.0671 | -0.609 | -1.16 | -1.35 | -1.1 | -3.73 | -5.05 |
EV/EBITDA |
-5.7 | -9.9 | -2.5 | -4.9 | 40.6 | -1.7 | -0.8 | -4.5 | -3.6 | 0.1 | -2.0 | |||
PEG |
0.0 | -0.0 | -0.0 | 0.02 | 0.02 | -0.1 | 0.0 | 0.36 | -0.05 | -0.1 | 0.22 | -0.1 | -0.02 | 0.0 |
P/B |
0.6 | 2.0 | 0.1 | 4.5 | 3.5 | 2.6 | 3.0 | 2.1 | 1.1 | 0.8 | 3.0 | 2.2 | 1.2 | 9.2 |
P/CF |
-0.4 | -0.9 | -0.1 | -7.0 | 8.0 | -4.2 | -7.1 | 31.6 | -2.6 | -1.6 | -7.0 | -7.5 | -0.8 | -2.5 |
ROE % |
53.84 | -129.30 | -103.89 | -83.52 | -61.22 | -35.09 | -79.41 | 5.25 | -50.09 | -54.68 | -60.07 | -32.08 | -163.58 | -377.98 |
ROA % |
42.97 | -26.35 | -30.62 | -23.73 | -22.49 | -20.35 | -38.29 | 4.79 | -44.23 | -50.49 | -54.51 | -30.61 | -118.04 | -162.69 |
ROCE % |
44.04 | -149.30 | -144.02 | -122.15 | -33.35 | -67.65 | -29.54 | 4.69 | -50.43 | -54.81 | -60.25 | -32.18 | -182.52 | -359.59 |
Current Ratio |
5.0 | 1.3 | 1.4 | 1.4 | 1.6 | 5.7 | 13.2 | 11.4 | 8.5 | 13.0 | 10.7 | 21.5 | 3.6 | 1.7 |
DSO |
- | - | - | - | - | 391.7 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 1139.6 | 493.6 | 409.9 | 393.1 | 42.7 | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | 391.7 | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | -1139.6 | -493.6 | -18.2 | -393.1 | -42.7 | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально MEI Pharma
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.2 | - | -1.66 | 8.46 | - | -2.32 | 1.54 | -2.49 | -0.05 | -1.31 | -0.1 | -0.16 | -0.26 | -0.11 | -0.07 | 0.01 | -0.1 | -0.02 | -0.26 | -0.04 | -0.26 | -0.24 | 0.17 | -0.21 | 0.17 | -0.21 | -0.16 | -0.24 | -0.16 | -0.24 | 0.32 | -0.12 | 0.32 | -0.16 | -0.15 | -0.13 | -0.15 | -0.13 | -0.39 | -0.42 | -0.39 | -0.42 | -0.32 | -0.29 | -0.32 | -0.29 | -0.5 | -0.7 | -0.5 | -0.12 | -0.78 | -1.01 | -0.13 | -0.17 |
EBITDA per Share |
-1.2 | - | -1.78 | 8.31 | - | - | 1.35 | -2.72 | -1.37 | -3.24 | -0.14 | -0.18 | -0.32 | -0.13 | -0.14 | -0.11 | -0.17 | -0.14 | -0.15 | -0.17 | -0.15 | -0.18 | -0.17 | -0.14 | -0.17 | -0.27 | -0.16 | -0.24 | -0.16 | -0.24 | 0.32 | -0.12 | 0.32 | -0.13 | -0.15 | -0.13 | -0.15 | -0.13 | -0.39 | -0.42 | -0.39 | -0.42 | -0.32 | -0.29 | -0.32 | -0.29 | -0.51 | -0.7 | -0.5 | -0.12 | -0.99 | -0.2 | -0.44 | -0.22 |
ROE % |
-0.09 | 5.75 | -39.18 | 0.61 | -68.30 | -80.46 | -48.39 | -86.16 | -92.65 | -140.46 | -178.64 | -172.28 | -136.82 | -92.43 | -43.92 | -59.87 | -70.44 | -81.02 | -84.81 | -36.16 | 12.49 | 61.13 | 30.89 | -7.45 | -50.11 | -88.44 | -72.04 | -34.54 | -24.45 | 19.93 | 29.85 | -1.68 | 0.15 | -36.92 | -34.40 | -37.02 | -52.67 | -64.30 | -76.47 | -74.74 | -66.54 | -55.60 | -43.60 | -43.51 | -118.22 | -168.88 | -214.56 | -243.13 | -200.76 | -226.77 | -263.05 | -48.05 | -85.90 | -89.86 |
ROA % |
-1.35 | 30.09 | 18.58 | 39.61 | -14.72 | -18.30 | -11.29 | -24.04 | -23.80 | -34.38 | -39.82 | -37.96 | -33.38 | -24.68 | -15.75 | -30.69 | -54.67 | -73.66 | -76.29 | -44.93 | -2.90 | 33.05 | 22.77 | -3.67 | -34.65 | -57.06 | -58.94 | -24.57 | -13.27 | 22.85 | 29.57 | -0.12 | -0.95 | -34.02 | -32.11 | -34.26 | -47.39 | -57.80 | -68.72 | -67.64 | -61.70 | -52.20 | -41.68 | -41.32 | -82.89 | -117.31 | -148.44 | -167.97 | -144.00 | -137.76 | -137.77 | -32.61 | -36.97 | -38.68 |
ROCE % |
-5.74 | 0.18 | -47.53 | -9.03 | -78.09 | -95.82 | -79.91 | -122.39 | -132.17 | -190.72 | -201.12 | -197.16 | -155.94 | -105.79 | -82.52 | -78.12 | -77.06 | -66.60 | -74.37 | -80.86 | -83.29 | -89.78 | -88.31 | -82.25 | -83.88 | -77.81 | -72.98 | -35.36 | -25.18 | 19.28 | 29.30 | -2.16 | -0.25 | -37.19 | -34.58 | -37.17 | -52.80 | -64.41 | -76.56 | -74.86 | -66.68 | -64.71 | -58.88 | -58.75 | -133.48 | -175.20 | -214.73 | -253.89 | -221.01 | -377.92 | -432.04 | -57.62 | -216.83 | -107.75 |
Current Ratio |
9.7 | 5.0 | 4.1 | 5.1 | 1.3 | 1.3 | 1.5 | 1.3 | 1.4 | 1.5 | 1.5 | 1.2 | 1.6 | 1.2 | 1.6 | 1.6 | 1.6 | 1.6 | 3.6 | 3.2 | 2.4 | 2.4 | 2.2 | 1.7 | 1.9 | 1.9 | - | - | 11.4 | - | - | 3.3 | 8.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.6 | - | - | - | 1.8 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | 38.6 | 58.8 | 23.3 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 1580.2 | 1101.8 | 789.9 | 450.1 | 490.8 | 436.8 | 522.9 | 681.5 | 460.6 | 167.9 | 239.8 | 329.5 | 218.3 | 115.3 | 98.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | 38.6 | 58.8 | 23.3 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | 38.6 | 58.8 | 23.3 | -1546.1 | -1101.8 | -789.9 | -450.1 | -490.8 | -436.8 | -522.9 | -681.5 | -460.6 | -167.9 | -239.8 | -329.5 | -218.3 | -115.3 | -98.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD